MAPATUMUMAB Drug Record

  • MAPATUMUMAB chembl:CHEMBL2108621 Antineoplastic

    Alternate Names:

    TRAIL-R 1MAB
    TRM-1 HGS-ETR1
    TRAIL-R1 MAB
    MAPATUMUMAB
    TRM-1
    HGS-1012
    HGS-ETR1
    HGS1012

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    Drug Class Therapeutic Antibodies
    (2 More Sources)

    Publications:

  • MyCancerGenome: MAPATUMUMAB

    • Version: 20-Jun-2017

    Alternate Names:
    HGS-ETR1 Development Name
    MAPATUMUMAB Generic Name

    Drug Info:
    Drug Class Therapeutic Antibodies

    Publications:

  • TdgClinicalTrial: MAPATUMUMAB

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

  • TTD: Mapatumumab

    • Version: 2020.06.01

    Alternate Names:
    D0KG5D TTD Drug ID

    Drug Info:

    Publications:

  • TALC: MAPATUMUMAB

    • Version: 12-May-2016

    Alternate Names:
    MAPATUMUMAB Primary Drug Name
    MAPATUMUMAB Drug Generic Name
    HGS-ETR1 Drug Synonym

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL2108621

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL2108621

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: